BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, Das K. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015;34:387-394. [PMID: 26614005 DOI: 10.1007/s12664-015-0598-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Cuny A, Guillo L, Baumann C, Netter P, Danese S, Caron B, Peyrin-biroulet L, Angioi K. Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era. JCM 2022;11:4538. [DOI: 10.3390/jcm11154538] [Reference Citation Analysis]
2 Schwartzman M, Ermann J, Kuhn KA, Schwartzman S, Weisman MH. Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD Open 2022;8:e001777. [PMID: 35046098 DOI: 10.1136/rmdopen-2021-001777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Koumaki D, Machaira A, Katoulis AC, Bitados P, Orfanoudaki E, Foteinogiannopoulou K, Stefanidou M, Krasagakis K, Koutroubakis IE. Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort. Eur J Gastroenterol Hepatol 2021;33:1387-93. [PMID: 33470697 DOI: 10.1097/MEG.0000000000002053] [Reference Citation Analysis]
4 Rawal KK, Shukla VP, Chikani S, Thakkar M, Ruparelia M, Chudasama RK. Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors. Indian J Gastroenterol 2021. [PMID: 34569013 DOI: 10.1007/s12664-021-01181-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Lo TC, Chen YY, Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye (Lond) 2021. [PMID: 34155367 DOI: 10.1038/s41433-021-01645-4] [Reference Citation Analysis]
7 Becciolini A, Di Donato E, Lucchini G, Santilli D, Mozzani F, Riva M, Ariani A. Imaging in the Assessment of Musculoskeletal Manifestations Associated with Inflammatory Bowel Disease. Gastroenterology Insights 2021;12:100-10. [DOI: 10.3390/gastroent12010010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Evans J, Sapsford M, McDonald S, Poole K, Raine T, Jadon DR. Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X21996973. [PMID: 33786068 DOI: 10.1177/1759720X21996973] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Park S, Wong Z, Park SH, Vu KV, Bang KB, Piyachaturawat P, Myint T, Hilmi I, Park D. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Digestive and Liver Disease 2021;53:196-201. [DOI: 10.1016/j.dld.2020.06.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Shah J, Shah A, Hassman L, Gutierrez A. Ocular Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izaa359. [PMID: 33501989 DOI: 10.1093/ibd/izaa359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Adam H, Alqassas M, Saadah OI, Mosli M. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. J Epidemiol Glob Health 2020;10:298-303. [PMID: 32959603 DOI: 10.2991/jegh.k.200330.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:740-54. [PMID: 32901108 DOI: 10.1038/s41575-020-0354-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
13 Attauabi M, Zhao M, Bendtsen F, Burisch J. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2021;27:927-39. [DOI: 10.1093/ibd/izaa167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Mosli MH, Saadah OI. Metabolic bone disease in children and adolescent patients with ulcerative colitis. J Pediatr (Rio J) 2021;97:242-7. [PMID: 32335076 DOI: 10.1016/j.jped.2020.03.003] [Reference Citation Analysis]
15 Nevares A, Raut R, Libman B, Hajj-ali R. Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-0885-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
16 Jumani L, Kataria D, Ahmed MU, Shah MAA, Raja K, Shaukat F. The Spectrum of Extra-intestinal Manifestation of Crohn's Disease. Cureus 2020;12:e6928. [PMID: 32190481 DOI: 10.7759/cureus.6928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Luzoro A, Sabat P, Guzmán L, Frias F. Manifestaciones extraintestinales de enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:305-14. [DOI: 10.1016/j.rmclc.2019.06.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Hiller A, Biedermann L, Fournier N, Butter M, Vavricka SR, Ciurea A, Rogler G, Scharl M; Swiss IBD Cohort Study Group. The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort. PLoS One 2019;14:e0211554. [PMID: 31039159 DOI: 10.1371/journal.pone.0211554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lee DH, Han JY, Park JJ, Cheon JH, Kim M. Ophthalmologic Manifestation of Inflammatory Bowel Disease: A Review. Korean J Gastroenterol 2019;73:269. [DOI: 10.4166/kjg.2019.73.5.269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. Clin Exp Immunol 2019;196:123-38. [PMID: 30554407 DOI: 10.1111/cei.13246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Vide J, Osório F, Costa-Silva M, Lopes S, Azevedo F, Camila Dias C, Magina S, Magro F. Cutaneous Morbidity Among Inflammatory Bowel Disease Patients: A Cohort Study. J Crohns Colitis 2018;12:442-51. [PMID: 29300856 DOI: 10.1093/ecco-jcc/jjx178] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
22 Yang BR, Choi NK, Kim MS, Chun J, Joo SH, Kim H, Lee J. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLoS One. 2018;13:e0200363. [PMID: 29990326 DOI: 10.1371/journal.pone.0200363] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
23 Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017;11:631-642. [PMID: 28453761 DOI: 10.1093/ecco-jcc/jjw199] [Cited by in Crossref: 26] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
24 Troncoso LL, Biancardi AL, de Moraes Jr HV, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol 2017; 23(32): 5836-5848 [PMID: 28932076 DOI: 10.3748/wjg.v23.i32.5836] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 37] [Article Influence: 11.4] [Reference Citation Analysis]
25 Aziz DA, Moin M, Majeed A, Sadiq K, Biloo AG. Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location. Pak J Med Sci 2017;33:793-7. [PMID: 29067041 DOI: 10.12669/pjms.334.12926] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Zhao Y, Wang J, Liu Z, Lin H, Shi Y, Sun X. Pulmonary dysfunction in 114 patients with inflammatory bowel disease. Medicine (Baltimore) 2017;96:e6808. [PMID: 28471982 DOI: 10.1097/MD.0000000000006808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
27 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
28 Thomas AS, Lin P. Ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2016;27:552-560. [PMID: 27585211 DOI: 10.1097/icu.0000000000000310] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
29 Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111-119. [PMID: 27175111 DOI: 10.5217/ir.2016.14.2.111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 180] [Article Influence: 26.5] [Reference Citation Analysis]